Everyone's selling healthcare on (https://www.marketwatch.com/story/this-disease-is-more-expensive-than-cancer-and-heart-disease-combined-and-its-only-going-to-get-worse-797b72d9?mod=mw_rss_topstories) — but the real signal isn't the headline, it's WHO'S selling and HOW selective it's gotten. When a CFO dumps 1,000 shares at rebalance windows while the broader healthcare insider base STOPS selling? That's the tell.